Position in MTD
as of Mar 31, 2026
· filed May 22, 2026
Position Value
$210,620
-$150,159 QoQ
Shares Held
167
-38.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MTD Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026GROUPAMA ASSET MANAGMENT holds $207,911,026 across 9 Diagnostics & Research names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
327,868 | $164,379,900 | |
| 2 | NTRA |
Natera, Inc.
|
95,558 | $25,939,219 | |
| 3 | DHR |
Danaher Corp /De/
|
53,570 | $10,204,013 | |
| 4 | QGEN |
Qiagen N.V.
|
130,000 | $5,083,000 | |
| 5 | WAT |
Waters Corp /De/
|
1,614 | $605,314 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
1,055 | $555,394 | |
| 7 | CRL |
Charles River Laboratories International, Inc.
|
2,121 | $481,021 | |
| 8 | A |
Agilent Technologies, Inc.
|
3,330 | $442,323 |
All Filings in MTD
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $210,620 | 167 | Shares | Sole | 2026-05-22 | |
| 2024-03-31 | $360,779 | 271 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $785,998 | 648 | Shares | Sole | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||